Delivery Order SPE2DR25D1205-SPE2DR26F1AC9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,196.22 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of November 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $38,297.64 delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 19, 2025, with performance taking place at the vendor's Conshohocken, Pennsylvania headquarters. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $29,995.79 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract carries no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a $15,402.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with a completion date of November 18, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The performance location is...
- The Defense Logistics Agency awarded a $15,965.27 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors on January 9, 2026, with completion targeted for January 12, 2026. This competitive, firm fixed-price delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. The contract carries no set-aside designation, reflecting full and open...
- The Defense Logistics Agency awarded a delivery order valued at $4,236.44 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pharmaceutical supplies. Executed on November 18, 2025, with an ultimate completion date of November 19, 2025, this firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a $34,089.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 9, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injector medication. The contract, with an ultimate completion date of January 12, 2026, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $136,951.37 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of September 17, 2025. This is a firm fixed price delivery order issued without set-aside designation, indicating competitive award. The order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,922.90 firm fixed-price delivery order for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of November 6, 2025. This competitively awarded contract, issued on November 5, 2025, represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors, with a contract ceiling value of $2,327.44 and an ultimate completion date of November 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F1AC9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $15,257.84 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract, awarded on January 16, 2026, with an ultimate completion date of January 20, 2026, is a firm fixed-price order with no set-aside designation, reflecting full and open competition. The award represents a task order execution under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This comprehensive IDC serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. The company's performance under this delivery order fulfills the Defense Logistics Agency's requirement for Repatha, a specialty cardiovascular medication, to support treatment programs across the Department of Defense healthcare infrastructure. The firm fixed-price structure and rapid completion timeline indicate this is a routine supply order drawn from the established IDC, leveraging AmerisourceBergen's extensive capabilities in managing complex pharmaceutical distribution networks for federal customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.3k | 1/15/26 |